Tīpoka ki te ihirangi
Welcome to University of UNSW, Bengaluru
Home
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Māori
Sign In
Ngā āpure katoa
Taitara
Kaituhi
Marau
Tau karanga
ISBN/ISSN
Tūtohu
Kimi
Whatutoto
Channels
Rapua ētahi atu hongere:
Kaupapa: Farnesoid X Receptor (FXR) agonist
Tāpirihia kia nui ake ngā hongere pēnei
Toggle additional channel list for Kaupapa: Farnesoid X Receptor (FXR) agonist
Kaupapa: HDV
Kaupapa: Milan criteria
Kaupapa: Pan-Peroxisome Proliferator-Activated Receptor (PPAR) agonists
Kaupapa: SARS-CoV-2
Kaupapa: TIPS
Kaupapa: acute-on-chronic liver failure
Kaupapa: acute-on-chronic liver failure (ACLF)
Kaupapa: alcoholic hepatitis
Kaupapa: alpha-fetoprotein
Kaupapa: ammonia
Kaupapa: anti-mineralocorticoids
Kaupapa: antivirals
Kaupapa: ascites
Kaupapa: autoantibodies
Kaupapa: bleeding
Kaupapa: cholangiocarcinoma
Kaupapa: cirrhosis
Kaupapa: cirrhotic ascites
Kaupapa: clinical trials
Kaupapa: colorectal cancer metastases
Kaupapa: decompensated cirrhosis
Kaupapa: decompensation
Kaupapa: effective hypovolemia
Kaupapa: functional cure
Kaupapa: furosemide
Kaupapa: hepatocellular carcinoma
Kaupapa: human albumin
Kaupapa: humoral response
Channel Options
Whakaatu tūemi hei hua rapu
Tūhuratia ngā hongere pātahi
Quick Look
New Therapies of Liver Diseases
Load more items
Kaupapa: HBV
Tāpirihia kia nui ake ngā hongere pēnei
Toggle additional channel list for Kaupapa: HBV
Kaupapa: HDV
Kaupapa: Milan criteria
Kaupapa: Pan-Peroxisome Proliferator-Activated Receptor (PPAR) agonists
Kaupapa: SARS-CoV-2
Kaupapa: TIPS
Kaupapa: acute-on-chronic liver failure
Kaupapa: acute-on-chronic liver failure (ACLF)
Kaupapa: alcoholic hepatitis
Kaupapa: alpha-fetoprotein
Kaupapa: ammonia
Kaupapa: anti-mineralocorticoids
Kaupapa: antivirals
Kaupapa: ascites
Kaupapa: autoantibodies
Kaupapa: bleeding
Kaupapa: cholangiocarcinoma
Kaupapa: cirrhosis
Kaupapa: cirrhotic ascites
Kaupapa: clinical trials
Kaupapa: colorectal cancer metastases
Kaupapa: decompensated cirrhosis
Kaupapa: decompensation
Kaupapa: effective hypovolemia
Kaupapa: functional cure
Kaupapa: furosemide
Kaupapa: hepatocellular carcinoma
Kaupapa: human albumin
Kaupapa: humoral response
Channel Options
Whakaatu tūemi hei hua rapu
Tūhuratia ngā hongere pātahi
Quick Look
New Therapies of Liver Diseases
Load more items
Ngā tūemi rite: New Therapies of Liver Diseases
Channel Options
Tiro pūkete
Tūhuratia ngā hongere pātahi
Quick Look
Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases
Quick Look
Biliary Atresia: Aetiology, Diagnosis and Treatment
Quick Look
Novel Challenges and Therapeutic Options for Liver Diseases
Quick Look
Hepatitis C
Quick Look
Management of Chronic Liver Diseases
Quick Look
Portal Hypertension & Cirrhosis
Quick Look
Journal of Liver Transplantation
Quick Look
Liver Research
Quick Look
Nutrition and Liver Disease
Quick Look
Hepatic Encephalopathy
Quick Look
The Digestive System in the Era of COVID-19
Quick Look
Cancer Biomarkers and Targets in Digestive Organs
Quick Look
Liver Cirrhosis
Quick Look
Stomach Disorders
Quick Look
Ascites
Quick Look
Liver Cancer
Quick Look
Liver Cancer
Quick Look
NASH and Systemic Complications
Quick Look
Editorial Board Members’ Collection Series
Quick Look
Journal of Liver Cancer
Quick Look
Ischemic Heart Disease in the Context of Different Comorbidities
Quick Look
JHEP Reports
Quick Look
Clinical Features and Long-Term Outcomes of Systemic Lupus Erythematosus
Quick Look
Annals of Hepatology
Load more items
Tiro pūkete
Tōmua
Tūhuratia ngā hongere pātahi
Panuku
